AC Immune SA, a clinical stage biopharmaceutical company, discovers, designs, and develops medicines and diagnostic products for the prevention and treatment of neurodegenerative diseases associated with protein misfolding.
Ac Immune Sa stock last closed at $2.35, up 2.17% from the previous day, and has decreased 29.43% in one year. It has underperformed other stocks in the Biotechnology industry by 0.16 percentage points. Ac Immune Sa stock is currently +39.88% from its 52-week low of $1.68, and -39.74% from its 52-week high of $3.90.
As of Jun 2, 2023, there are 83.62M shares of ACIU outstanding. The market cap of ACIU is $196.51M. In the past 24 hours, 131,665 ACIU shares were traded.
You will need a brokerage account in order to access the NASDAQ market and buy ACIU stock.
In our opinion, eToro is the best brokerage. eToro gives you:
Get $10 towards your purchase of stock by signing up for an account with eToro today.Open eToro Account
Now that you've chosen the best brokerage, you'll need to fill out some personal info so you are able to invest in ACIU stock today.
Now that you've created your account on one of the best stock trading apps, you can securely and quickly fund your account:
Watch the walkthrough below if you need help transferring money into your investment account.
After you have identified the best place to buy Ac Immune Sa stock, it's absolutely critical to evaluate their stock before you invest, so you truly comprehend the risk as well as the opportunity.
WallStreetZen was built to help part-time investors perform more accurate fundamental analysis.
You can see all of the due diligence checks on ACIU's stock page.
Investors use a variety of different financial metrics, analyses, models, and charts to gauge ACIU's fair value.
Using relative valuations metrics:
You can access additional valuation analysis on ACIU's stock here.
Out of 1 sell side analysts who monitor ACIU, the consensus analyst rating on Ac Immune Sa is a Buy
Please note that analyst ratings are not stock recommendations, nor are they investment advice.
Andrew Fein, a top 8% analyst from HC Wainwright & Co. reiterates ACIU with a buy rating and maintains their ACIU price target from $16.00 to $16.00, on May 1, 2023.
You can dig deeper into what analysts are saying on the Ac Immune Sa stock forecast page.
Last year, ACIU revenue was $4.42M. In the last five year, ACIU's revenue has increased by -26.77% per year. This was slower than the Biotechnology industry average of 90.44%.
You can analyze ACIU's earnings and revenue performance here.
Over the last 12 months, insiders at ACIU have not bought or sold any shares.
Research more about who owns ACIU stock here.
No, Ac Immune Sa doesn't provide an income stream by paying out dividends.
One of the primary reasons eToro is our favorite brokerage is because of its social trading community.
Click below to see what other traders have to say.
There are two primary order types:
Press the Open Trade button and eToro will execute the order.
If you need more assistance investing in stocks on eToro, watch the how to video below:
Now that you own some shares in ACIU, you'll want to stay up-to-date on your shares.
Make a watchlist to keep tabs on your ACIU stock.
To summarize, here are the 6 steps to buy stock in Ac Immune Sa:
If you are looking for a brokerage account, eToro is our recommended venue.Get Started with eToro Today
If you would like to track your investment in Ac Immune Sa, add ACIU to your watchlist below.
How much does it cost to buy one Ac Immune Sa share?
Is now a good time to buy Ac Immune Sa stock?
What is the best way to buy Ac Immune Sa stock?